Xeris Pharmaceuticals Inc. (XERS) Misses Q3 EPS by 2c, provides guidance

Go back to Xeris Pharmaceuticals Inc. (XERS) Misses Q3 EPS by 2c, provides guidance
(NASDAQ: XERS) Delayed: 6.93 +0.22 (3.28%)
Previous Close $6.71    52 Week High
Open $6.68    52 Week Low
Day High $7.07    P/E N/A 
Day Low $6.61    EPS
Volume 3,135,083